Journal rankings · indicator year 2020
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2020
Cellular and Molecular Neuroscience journal rankings 2020
33 ranked journals · Subfield in Neuroscience
Cellular and Molecular Neuroscience has 33 ranked journals in 2020. The median journal has an OJR of 1.00, level with the world average of 1.00, down 0.03 on 2019; Q1 starts at OJR 1.42. The top three are Neuropsychopharmacology, Frontiers in Cellular Neuroscience, and Fluids and Barriers of the CNS.
Ranks and citation indicators: 2020. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2017–2019, the window the 2020 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Neuroscience (8)
33 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2019. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2017–2019, the window the 2020 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2017–2019 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2011 to 2020. | Compare |
|---|---|---|---|---|---|---|---|
1NeuropsychopharmacologySpringer Nature · United States | 2.30Q1 | 6.92 1.10 up from 2019 | 856 | 98% | $5,290 | ||
2Frontiers in Cellular NeuroscienceOAFrontiers Media · Switzerland | 1.84Q1 | 6.34 1.50 up from 2019 | 1,503 | 100% | $3,801 | ||
3Fluids and Barriers of the CNSOABioMed Central · United Kingdom | 1.84Q1 | 8.62 2.96 up from 2019 | 99 | 100% | $3,390 | ||
4Molecular BrainOABioMed Central · United Kingdom | 1.71Q1 | 4.66 1.02 down from 2019 | 254 | 100% | $2,890 | ||
5NeuropharmacologyElsevier BV · Netherlands | 1.66Q1 | 5.01 0.35 up from 2019 | 1,307 | 48% | $4,300 | ||
6Frontiers in Synaptic NeuroscienceOAFrontiers Media · Switzerland | 1.50Q1 | 4.83 0.30 up from 2019 | 98 | 100% | $3,801 | ||
7Frontiers in NeuroanatomyOAFrontiers Media · Switzerland | 1.49Q1 | 4.57 0.53 up from 2019 | 348 | 100% | $3,801 | ||
8Brain and Neuroscience AdvancesOASAGE Publishing · United States | 1.43Q1 | 4.95 2.35 up from 2019 | 75 | 100% | $1,438 | ||
9PsychopharmacologySpringer Science+Business Media · Germany | 1.42Q1 | 4.59 0.76 up from 2019 | 879 | 56% | $4,390 | ||
10Frontiers in Neural CircuitsOAFrontiers Media · Switzerland | 1.32Q2 | 4.09 0.26 up from 2019 | 305 | 100% | $3,801 | ||
11Addiction BiologyOAWiley · United Kingdom | 1.23Q2 | 3.72 0.23 up from 2019 | 359 | 58% | $3,150 | ||
12Journal of Neuroscience ResearchWiley · United States | 1.22Q2 | 3.77 0.34 up from 2019 | 480 | 48% | $4,840 | ||
13Journal of Experimental NeuroscienceOASAGE Publishing · United States | 1.19Q2 | 3.56 1.28 up from 2019 | 69 | — | $1,500 | ||
14Developmental NeurobiologyWiley · United States | 1.11Q2 | 2.91 1.32 down from 2019 | 186 | 54% | $4,550 | ||
15Pharmacology Biochemistry and BehaviorElsevier BV · United States | 1.09Q2 | 3.52 0.42 up from 2019 | 361 | 38% | $3,650 | ||
16Journal of Neurosurgery PediatricsUnited States | 1.09Q2 | 2.90 0.41 up from 2019 | 516 | 63% | — | ||
17The CerebellumSpringer Science+Business Media · United Kingdom | 1.00Q2 | 3.81 1.19 up from 2019 | 239 | 46% | $4,790 | ||
18Journal of Comparative Physiology ASpringer Science+Business Media · Germany | 0.88Q3 | 2.07 0.47 up from 2019 | 264 | 47% | $3,990 | ||
19Cerebellum & AtaxiasBioMed Central · United Kingdom | 0.87Q3 | 2.46 0.65 down from 2019 | 48 | 100% | $2,090 | ||
20NeuropeptidesElsevier BV · United Kingdom | 0.86Q3 | 3.15 0.55 up from 2019 | 193 | 16% | $3,530 | ||
21Journal of Chemical NeuroanatomyElsevier BV · Netherlands | 0.86Q3 | 2.65 0.13 up from 2019 | 240 | 14% | $3,230 | ||
22AlcoholElsevier BV · United Kingdom | 0.84Q3 | 2.41 0.33 up from 2019 | 316 | 59% | $3,720 | ||
23Neuronal SignalingOAPortland Press · United Kingdom | 0.83Q3 | 3.00 0.48 up from 2019 | 37 | 100% | $2,225 | ||
24SynapseWiley · United States | 0.82Q3 | 2.57 0.32 up from 2019 | 125 | 33% | $3,570 | ||
25The Journal of Comparative NeurologyWiley · United States | 0.80Q3 | 2.83 0.34 up from 2019 | 639 | 58% | $5,450 | ||
26Behavioural PharmacologyLippincott Williams & Wilkins · United Kingdom | 0.79Q4 | 2.32 0.54 up from 2019 | 249 | 43% | — | ||
27Journal of Huntington s DiseaseIOS Press · Netherlands | 0.68Q4 | 2.11 0.71 down from 2019 | 127 | 58% | $4,150 | ||
28Bioelectronics in MedicineFuture Medicine · United Kingdom | 0.56Q4 | 1.45 0.67 down from 2019 | 41 | 43% | — | ||
29Child s Nervous SystemSpringer Science+Business Media · Germany | 0.54Q4 | 1.47 0.04 up from 2019 | 1,038 | 20% | $4,790 | ||
30Journal of NeurogeneticsTaylor & Francis · Switzerland | 0.45Q4 | 1.05 0.63 down from 2019 | 95 | 52% | — | ||
31Invertebrate NeuroscienceSpringer Science+Business Media · Germany | 0.45Q4 | 1.71 0.68 up from 2019 | 40 | 33% | $3,860 | ||
| 0.26Q4 | 0.50 0.36 down from 2019 | 32 | 0% | — | |||
33Opera medica et physiologicaPublisher not listed | 0.02Q4 | 0.13 0.01 down from 2019 | 39 | 0% | — |
Subfields of Neuroscience, with Cellular and Molecular Neuroscience highlighted.
- Cognitive Neuroscience260
- Cellular and Molecular Neuroscience33
- Neurology20
- Sensory Systems8
- Behavioral Neuroscience4
- Endocrine and Autonomic Systems4
- Biological Psychiatry3
- Developmental Neuroscience0
Journals
Citations made in 2020. Corpus-wide, 86.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
7 additional Cellular and Molecular Neuroscience journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2017–2019, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2020. Publication window: 2017–2019. How these summaries are calculated
- Ranked journals
- 33
- Window papers (baseline)
- 39,604 -5.1% from indicator year 2017
- Median OJR
- 1.004 -12.6% from indicator year 2017
- Rising journals (2025)
- 1
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2017–2019 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 27 | 27 | 26 | 27 | 27 | 32 | 32 | 32 | 31 | 27 | 30 | 32 | 33 | 32 | 30 | 30 | 32 | 32 | 29 | 32 | 33 | 33 | 33 | 32 | 31 | 30 | |
| Window papers (baseline) | 37,773 | 38,664 | 38,213 | 37,940 | 37,414 | 38,123 | 38,289 | 38,810 | 38,951 | 41,086 | 41,577 | 41,975 | 41,244 | 41,433 | 42,264 | 42,615 | 42,554 | 41,749 | 40,554 | 39,909 | 39,604 | 39,824 | 40,023 | 39,750 | 39,038 | 38,750 | |
| Median OJR | 0.73 | 0.74 | 0.83 | 0.790 | 0.86 | 0.894 | 0.91 | 0.885 | 0.94 | 1.16 | 1.18 | 1.12 | 1.07 | 1.147 | 1.14 | 1.153 | 1.13 | 1.149 | 1.146 | 1.04 | 1.004 | 0.997 | 0.93 | 0.88 | 0.90 | 0.791 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.